Search

It has been six years since a French biotech company made a stock market debut – and now two, BioAlliance and ExonHit, are doing so. Is the European market reawakening?

"Scientific work … must be done for itself, for the beauty of science." Marie Curie, chemist & physicist (1867 - 1934)

The pace of forming academic spin-out companies picked up in the US in 2004 after a two-year slump, according to a survey released today.

Not all nanotechnology is hype. Carbon nanotubes are already inside a product near you.

Britain's privatised defence lab ties up with 7 universities, in a strategy to do more with fewer partners.

Tracking 15 key technologies, fraud in nanotechnology - and other insights into R&D management

Nanonucleant, a spin-out of Imperial College London, is seeking angel financing to move ahead with a glass grain-based technology that aids in crystallising proteins for study as drug targets.

With an estimated 400 million people at risk for developing dementia, a natural remedy would be a welcome answer. That's the approach one British company is taking.

A team of European researchers is applying a technology used to measure airflow over aircraft wings to improve human heart implants.

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.

Nuala Moran takes a behind-the-scenes look at the strategies involved in Europe's biggest patent victory in years.

The University of Cambridge is considering whether to make more cash available to invest in campus spin-off companies. And whatever decision it makes will come in for criticism…

Jo Taylor, head of venture capital at 3i Group, argues that universities are too quick to hit the spin-out button.

Universities are funding more campus companies. Richard L. Hudson on the rules of a very risky game.

Reports of incubators' demise were premature

For her latest fortnightly funding column, Mary Lisbeth D'Amico set out to find European seed funders. That was as easy as finding a needle in a haystack.

Four years ago, some of Gerd Zettlmeissl’s friends thought he was crazy to leave his top job at vaccine giant Chiron to work for an Austrian spin-out company a tenth Chiron's size...

The Cambridge-based company a.gain medical says it has invented the world's first urethral sensor for women – and is looking for further investment.

UK-based AMDG's monitor for early detection of heart conditions particularly associated with diabetics is already selling in Germany. Now the company is now looking for support to enter into the US market.

A spin-out from Sheffield that uses stem cells to help with conventional drug discovery is looking for investment to continue pre-clinical research on therapeutic applications and business development activities.